Results 191 to 200 of about 185,701 (264)

Anticoagulants beyond coagulation: a narrative review of cardiovascular effects. [PDF]

Cardiovasc Res
Aarts A, Ten Cate H, Ten Cate-Hoek AJ.
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity‐Matched Cohort Study

Clinical Pharmacology &Therapeutics, EarlyView.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies (mAbs) lower LDL cholesterol and may influence cancer through immunomodulatory pathways. However, their effect on human cancer incidence remains unknown. We conducted a retrospective, propensity score‐matched study (Clalit Health Services, Israel, 2010–2023) comparing PCSK9 ...
Inbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat, Shiri Kushnir, Guy Witberg, Amos Levi, Dan Gilon, Ran Kornowski, Paaladinesh Thavendiranathan, Husam Abdel Qadir, Zaza Iakobishvili   +10 more
wiley   +1 more source

Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use

Clinical Pharmacology &Therapeutics, EarlyView.
The impact of the choice of common data model (CDM) approach on the study results in a real‐world evidence (RWE) study is unknown. We aimed to determine potential differences in the results of an RWE study when data were mapped to two different CDMs, ConcePTION and OMOP. With the same instance of CPRD GOLD, data were mapped to both CDMs. Using the same
Nicholas B. Hunt, Patrick Souverein, Marloes Bazelier, Nicola Barclay, Antonella Delmestri, Miriam Sturkenboom, Daniel Prieto‐Alhambra, Helga Gardarsdottir, Olaf Klungel   +8 more
wiley   +1 more source

DOACs reduce risk for new-onset portal hypertension in patients with cirrhosis and atrial fibrillation: A retrospective cohort study. [PDF]

Medicine (Baltimore)
Su Y, Wang J, Dong Q, Guan H, Ma C.
europepmc   +1 more source

Post-acute care and secondary prevention after ischaemic stroke [PDF]

, 2011
Higgins, P., Langhorne, P., McArthur, K.S., Quinn, T.J.   +3 more
core   +1 more source

Extended thromboprophylaxis after hip fracture surgery: Real-world evidence of direct oral anticoagulants versus low molecular weight heparin of unfractionated heparin. [PDF]

PLoS One
Clavijo MM, Ruiz JI, Brindicci MR, Rodriguez P, Wauters V, Reparaz MLAV, Mountford A, Monteagudo M, Camarero M, Casali CE, Mahuad C, Aizpurua F, Zerga ME, Ventura A, Siciliano N, Garate G.   +15 more
europepmc   +1 more source

Flexible Phase Change Bandage Incorporated With Zeolite for Temperature‐Controlled Wound Hemostasis

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
A novel flexible hemostatic phase change bandage (HPB) was designed and constructed through chemical cross‐linking and electrospinning to mitigate thermal injury and broaden the application of PCMs in the medical field. Furthermore, the flexible HPB shows thermal stability, strong mechanical strength, excellent infiltration, and reliable thermal ...
Xinyu Zhang, Keyan Sun, Hanqing Liu, Shihui Zhang, Yan Kou, Haocheng Fu, Zicheng Lu, Yongfei Zhao, Quan Shi   +8 more
wiley   +1 more source

Efficacy and Safety of Anticoagulants in Patients With Idiopathic Pulmonary Fibrosis: A Meta-Analysis. [PDF]

Can Respir J
Yang S, Xie D, Wang J, Yang Z, Xue X.
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Management of venous thrombosis in sickle cell disease: a comparative study on the use of direct oral anticoagulants and warfarin. [PDF]

Res Pract Thromb Haemost
Almegren M, AlSolamy EN, Qutob RA, Alasmari MM, Aljeraiwi A, Aljuwaisri N, Alshuaibi TA, Bahammam F, Al Rawahi B, Al Farsi HH.   +9 more
europepmc   +1 more source